Literature DB >> 24427718

Otoacoustic emission responses of the cochlea to acute and total ischemia.

Yavuz Selim Yıldırım1, Fadlullah Aksoy2, Orhan Ozturan2, Bayram Veyseller2, Hasan Demirhan3.   

Abstract

In the present experimental study, we sought to monitor distortion product otoacoustic emissions (DPOAEs) as an indicator of cochlear function, after sudden, total, and irreversible interruption of cochlear blood flow, to provide information on the time course of cochlear response to ischemia. Twenty rats with normal hearing function were included. Complete and abrupt ischemia was provided by decapitation. DPOAEs at 3-8 kHz frequencies were recorded at baseline and exactly every consecutive minute after decapitation, until emissions in all frequencies disappeared completely. Mean DPOAE values decreased significantly and progressively after decapitation for all frequencies. The mean duration of emissions was 8.20 ± 1.96 min (minimum 3 min, maximum 11 min). The longest durations of DPOAEs were observed with 4 and 5 kHz frequencies, and 3 and 6 kHz had the shortest durations. The outer hair cells exposed to acute ischemia seem to exhibit a rapid functional loss; thus, cautious handling of the cochlear vasculature and surrounding structures is necessary in surgical interventions. Additionally, our results provide some idea of the normal tolerance range of the cochlea to ischemia, which could be useful for future studies.

Entities:  

Keywords:  Cochlear blood flow; Cochlear ischemia; Otoacoustic emissions; Outer hair cell; Rat

Year:  2012        PMID: 24427718      PMCID: PMC3889377          DOI: 10.1007/s12070-012-0561-2

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  20 in total

1.  Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli.

Authors:  Paul Avan; Pierre Bonfils; Laurent Gilain; Thierry Mom
Journal:  J Acoust Soc Am       Date:  2003-01       Impact factor: 1.840

2.  Experiments on temporary obstruction of the internal auditory artery.

Authors:  H B PERLMAN; R KIMURA; C FERNANDEZ
Journal:  Laryngoscope       Date:  1959-06       Impact factor: 3.325

3.  Blood flow in the ears of patients receiving cochlear implants.

Authors:  Tsutomu Nakashima; Taku Hattori; Michihiko Sone; Eisuke Sato; Mitsuo Tominaga; Makoto Sugiura
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-06       Impact factor: 1.547

4.  The fate of outer hair cells after acoustic or ototoxic insults.

Authors:  Karen A Abrashkin; Masahiko Izumikawa; Toru Miyazawa; Chih-Hung Wang; Mark A Crumling; Donald L Swiderski; Lisa A Beyer; Tzy-Wen L Gong; Yehoash Raphael
Journal:  Hear Res       Date:  2006-06-14       Impact factor: 3.208

5.  Distortion product otoacoustic emissions and basilar membrane vibration in the 6-9 kHz region of sensitive chinchilla cochleae.

Authors:  William S Rhode
Journal:  J Acoust Soc Am       Date:  2007-11       Impact factor: 1.840

6.  Hemoconcentration as a possible pathogenic factor of sudden hearing loss.

Authors:  M Suckfüll; K Mees
Journal:  Eur Arch Otorhinolaryngol       Date:  1998       Impact factor: 2.503

7.  Laser light transmission and laser Doppler blood flow measurements on the human, rat and guinea pig cochlea.

Authors:  F Scheibe; H Haupt; H Berndt; S Magnus; P Weymar
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

8.  Toluene ototoxicity in rats: assessment of the frequency of hearing deficit by electrocochleography.

Authors:  R Lataye; P Campo; G Loquet
Journal:  Neurotoxicol Teratol       Date:  1999 May-Jun       Impact factor: 3.763

Review 9.  Disorders of cochlear blood flow.

Authors:  Tsutomu Nakashima; Shinji Naganawa; Michihiko Sone; Mitsuo Tominaga; Hideo Hayashi; Hiroshi Yamamoto; Xiuli Liu; Alfred L Nuttall
Journal:  Brain Res Brain Res Rev       Date:  2003-09

Review 10.  Otoacoustic emissions, their origin in cochlear function, and use.

Authors:  David T Kemp
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.